RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models

Key Takeaways Revvity joins forces with Eli Lilly to offer TuneLab models via the Signals Xynthetica platform.The deal tackles AI drug discovery bottlenecks using federated learning and secure knowledge sharing.RVTY will co-fund select biotechs, lowering entry barriers and supporting adoption of the Signals ecosystem.Revvity, Inc. (RVTY) recently announced a collaboration with Eli Lilly and Company to make Eli Lilly’s TuneLab predictive models available through the Revvity Signals platform. The partnership ...